Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous cinaciguat in acute decompensated chronic congestive heart failure
2007-003059-36Phase 2Terminated
- Sponsor
- Bayer
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Cinaciguat with Placebo (2 arms). Primary endpoint: Change in pulmonary capillary wedge pressure at 8 hours. Started Oct 2007; status: terminated.
02
Drugs
cinaciguat
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2007-003059-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003059-36.